Navigation Links
BioSoteria CEO to Present at Drug Safety Conference

BioSoteria announced that its President and CEO Sally Van Doren, PharmD, will present at the 9th DIA Conference for Contemporary Pharmacovigilance and Risk Management Strategies, which takes place January 10-13, 2010, in Washington, DC. Dr. Van Doren will present on the topic of the Integrated Summary of Safety.

Emeryville, CA (PRWEB) November 18, 2009 -- BioSoteria, Inc., a drug safety service provider and training company, announced today that its President and Chief Executive Officer Sally Van Doren, PharmD, will present at the 9th Drug Information Association (DIA) Conference for Contemporary Pharmacovigilance and Risk Management Strategies. The meeting will take place January 10-13, 2010, in Washington, DC.

Dr. Van Doren will present on the topic of the Integrated Summary of Safety (ISS) during the session regarding Safety Reporting for Drugs and Biologics. Her talk will focus on the practical aspects of authoring the ISS, such as project planning, data pooling decisions, and integration points with the Common Technical Document and the product label.

"After authoring numerous safety analyses over the years, I have learned that the ISS is not as straight-forward as it appears in content requirements," said Dr. Van Doren. "I look forward to sharing my experience with this audience of drug safety professionals."

The DIA Conference for Contemporary Pharmacovigilance and Risk Management has become an important annual meeting for drug safety practitioners. The three-day program addresses regulatory activities and the complexities involved in maximizing the benefits and minimizing the risks of pharmaceuticals throughout all phases of development and marketed use. For more information, please visit the DIA website at

About Sally Van Doren, PharmD
Dr. Van Doren is the President, Chief Executive Officer and Founder of BioSoteria, the fastest-growing drug safety service provider and training company based on the West Coast. With more than twenty years of pharmaceutical industry experience, Dr. Van Doren has held leadership positions in drug safety and risk management, clinical development, and medical information services. She has been directly involved in numerous safety analyses for US and European product marketing applications and has advised many companies on a broad range of safety issues.

About BioSoteria, Inc.
BioSoteria is an innovative drug safety services and education provider to the biopharmaceutical industry. BioSoteria offers a wide range of consulting and operational services in clinical safety, postmarketing pharmacovigilance, and pharmaceutical risk management. To learn more about BioSoteria, please visit the company's website or call toll-free at 1-866-660-5553, extension 010.


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. BioSoteria Drug Safety Newsletter Reaches Milestone
2. BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification
3. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
4. Avicena Group to Present at Noble Financial Conference
5. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
6. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
7. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
8. CEL-SCI to Present at the Noble Financial Conference
9. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
10. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
11. Strategic Diagnostics Updates Roth Conference Presentation Time
Post Your Comments:
Related Image:
BioSoteria CEO to Present at Drug Safety Conference
(Date:11/25/2015)... SAN DIEGO , Nov. 25, 2015 ... that management will participate in a fireside chat discussion ... New York . The discussion is ... Time. .  A replay will ... Contact:  Media Contact:McDavid Stilwell  , Julie NormartVP, Corporate ...
(Date:11/24/2015)... KUALA LUMPUR, Malaysia , Nov. 24, 2015 ... the global contract research organisation (CRO) market. The ... to result in lower margins but higher volume ... With increased capacity and scale, however, margins in ... Contract Research Organisation (CRO) Market ( ...
(Date:11/24/2015)... , Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... in New York on Wednesday, December 2 ... Torley , president and CEO, will provide a corporate overview. ... York at 1:00 p.m. ET/10:00 a.m. PT . ... relations, will provide a corporate overview. --> th ...
(Date:11/24/2015)... Tampa, Florida (PRWEB) , ... November 24, 2015 ... ... its biggest event of the year and one of the premier annual events ... USA, and ran from 8–11 November 2015, where ISPE hosted the largest number ...
Breaking Biology Technology:
(Date:11/10/2015)... LONDON , Nov. 10, 2015 /PRNewswire/ ... segmented on the basis of product, type, ... segments included in this report are consumables, ... this report are safety biomarkers, efficacy biomarkers, ... in this report are diagnostics development, drug ...
(Date:11/9/2015)... , Nov. 9, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced broader entry into the automotive market ... that match the pace of consumer electronics human interface ... sensors are ideal for the automotive industry and will ... Europe , Japan ...
(Date:10/29/2015)... MINNETONKA, Minn. , Oct. 29, 2015   ... that supports the entire spectrum of clinical research, is ... the Minnesota High Tech Association (MHTA) as one of ... in the "Software – Small and Growing" category. The ... and individuals who have shown superior technology innovation and ...
Breaking Biology News(10 mins):